{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:49:21Z","timestamp":1792028961356,"version":"4.4.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Burns"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.burns.2025.107785","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T11:48:55Z","timestamp":1763639335000},"page":"107785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The burn repair molecule? Evaluating FGF-21 in thermal injury \u2013 A systematic review"],"prefix":"10.1016","volume":"52","author":[{"given":"Tobias","family":"Niederegger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Schaschinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4703-0835","authenticated-orcid":false,"given":"Jule","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Knoedler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Knoedler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alen","family":"Palackic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1278-0505","authenticated-orcid":false,"given":"Felix J.","family":"Klimitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothea","family":"Noll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Most","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3419-4830","authenticated-orcid":false,"given":"Julia","family":"Ritterhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana C.","family":"Panayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Hundeshagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.burns.2025.107785_bib1","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00101.2017","article-title":"Fibroblast growth factor 21: a regulator of metabolic disease and health span","volume":"313","author":"Xie","year":"2017","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.burns.2025.107785_bib2","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3945\/ajcn.110.001941","article-title":"Fibroblast growth factor 21 is a metabolic regulator that plays a role in the adaptation to ketosis","volume":"93","author":"Domouzoglou","year":"2011","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"10.1016\/j.burns.2025.107785_bib3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S2352-4642(17)30122-0","article-title":"Long-term effect of critical illness after severe paediatric burn injury on cardiac function in adolescent survivors: an observational study","volume":"1","author":"Hundeshagen","year":"2017","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.burns.2025.107785_bib4","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/j.yjmcc.2022.08.147","article-title":"Chronic heart failure as a sequel after severe burn injury \u2013 first insight into a novel pathological heart-skin axis","volume":"173","author":"Mertin","year":"2022","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.burns.2025.107785_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/burnst\/tkac031","article-title":"Current understanding of thermo(dys)regulation in severe burn injury and the pathophysiological influence of hypermetabolism, adrenergic stress and hypothalamic regulation-a systematic review","volume":"10","author":"Mertin","year":"2022","journal-title":"Burns Trauma"},{"issue":"3","key":"10.1016\/j.burns.2025.107785_bib6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3390\/ebj6030043","article-title":"Post-traumatic stress disorder (PTSD) is associated with increased physical skin symptom burden following severe burn injuries: subgroup analysis of a multicenter prospective cohort","volume":"6","author":"Klimitz","year":"2025","journal-title":"Eur Burn J"},{"key":"10.1016\/j.burns.2025.107785_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev-nutr-071816-064800","article-title":"Fibroblast growth factor 21: a versatile regulator of metabolic homeostasis","volume":"38","author":"BonDurant","year":"2018","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.burns.2025.107785_bib8","article-title":"Fibroblast growth factor 21: an emerging pleiotropic regulator of lipid metabolism and the metabolic network","volume":"11","author":"Li","year":"2023","journal-title":"Genes Dis"},{"key":"10.1016\/j.burns.2025.107785_bib9","doi-asserted-by":"crossref","DOI":"10.1186\/2197-425X-3-S1-A977","article-title":"Fibroblast growth factor 21 response to critical illness: effect of blood glucose control and relation with mitochondrial dysfunction, the integrated stress response and survival","volume":"3","author":"Thiessen","year":"2015","journal-title":"Intensive Care Med Exp"},{"key":"10.1016\/j.burns.2025.107785_bib10","doi-asserted-by":"crossref","DOI":"10.18705\/1607-419X-2024-2455","article-title":"Fibroblast growth factor 21: a novel link in the development and treatment of metabolic disorders","author":"Mikhailova","year":"2025","journal-title":"\"Arter\u2019naya Gipertenz\" (\"Arter Hypertens\")"},{"key":"10.1016\/j.burns.2025.107785_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bmt.2024.09.005","article-title":"Biomaterials that passively and actively target macrophages promote the regeneration of injured tissues","volume":"8","author":"Zhuang","year":"2024","journal-title":"Biomed Technol"},{"issue":"5","key":"10.1016\/j.burns.2025.107785_bib12","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s42765-023-00310-7","article-title":"Oxygen atom-concentrating short fibrous sponge regulates cellular respiration for wound healing","volume":"5","author":"Fu","year":"2023","journal-title":"Adv Fiber Mater"},{"key":"10.1016\/j.burns.2025.107785_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1053997","article-title":"Emerging roles of fibroblast growth factor 21 in critical disease","volume":"9","author":"Yan","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.burns.2025.107785_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/SMMD.20230034","article-title":"Electrospun fiber-based immune engineering in regenerative medicine","volume":"3","author":"Xu","year":"2024","journal-title":"Smart Med"},{"issue":"0","key":"10.1016\/j.burns.2025.107785_bib15","first-page":"14","article-title":"Regenerative peripheral nerve interfaces (RPNIs): an overview of innovative surgical approaches","volume":"11","author":"Berberoglu","year":"2024","journal-title":"Plast Aesthetic Res"},{"issue":"0","key":"10.1016\/j.burns.2025.107785_bib16","first-page":"50","article-title":"Cell-supplemented autologous fat grafting: a review from bench to bedside","volume":"11","author":"Ghosh","year":"2024","journal-title":"Plast Aesthetic Res"},{"key":"10.1016\/j.burns.2025.107785_bib17","first-page":"1","article-title":"Cellular senescence\u2014from solid organs to vascularized composite allotransplants","author":"Knoedler","year":"2025","journal-title":"GeroScience"},{"issue":"4","key":"10.1016\/j.burns.2025.107785_bib18","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/TA.0000000000003349","article-title":"Long-term sequelae of critical illness in sepsis, trauma and burns: a systematic review and meta-analysis","volume":"91","author":"Haug","year":"2021","journal-title":"J Trauma Acute Care Surg"},{"issue":"1","key":"10.1016\/j.burns.2025.107785_bib19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE\u2019s risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.burns.2025.107785_bib20","unstructured":"Wells G.A., Wells G., Shea B., Shea B., O'Connell D., Peterson J., et al., editors. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses2014."},{"key":"10.1016\/j.burns.2025.107785_bib21","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"Bmj"},{"key":"10.1016\/j.burns.2025.107785_bib22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jclinepi.2021.08.022","article-title":"Cochrane's risk of bias tool for non-randomized studies (ROBINS-I) is frequently misapplied: a methodological systematic review","volume":"140","author":"Igelstr\u00f6m","year":"2021","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.burns.2025.107785_bib23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/PRS.0b013e318219c171","article-title":"The levels of evidence and their role in evidence-based medicine","volume":"128","author":"Burns","year":"2011","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.burns.2025.107785_bib24","article-title":"Fibroblast growth factor 21 and browning of white adipose tissue","volume":"10","author":"Matteis","year":"2019","journal-title":"Front Physiol"},{"key":"10.1016\/j.burns.2025.107785_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2014.00107","article-title":"FGF21 as a hepatokine, adipokine, and myokine in metabolism and diseases","volume":"5","author":"Itoh","year":"2014","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.burns.2025.107785_bib26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.molmet.2015.11.002","article-title":"Muscle mitochondrial stress adaptation operates independently of endogenous FGF21 action","volume":"5","author":"Ost","year":"2015","journal-title":"Mol Metab"},{"key":"10.1016\/j.burns.2025.107785_bib27","unstructured":"Schothorst E., Ost M., Stelt I., Klaus S., Keijer J. Muscle mitochondrial stress-induced metabolic adaptations do not require FGF21 action. 2016."},{"key":"10.1016\/j.burns.2025.107785_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-019-2103-2","article-title":"Browning of white adipose tissue after a burn injury promotes hepatic steatosis and dysfunction","volume":"10","author":"Abdullahi","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.burns.2025.107785_bib29","article-title":"Browning of White Adipose Tissue May be an Appropriate Adaptive Response to Critical Illness","author":"McClave","year":"2023","journal-title":"JPEN J Parenter Enter Nutr"},{"issue":"62","key":"10.1016\/j.burns.2025.107785_bib30","first-page":"1","article-title":"A novel approach to burn-induced cardiac damage: the role of hepatic FGF21 in aged mice","volume":"2024","author":"Monge","year":"2024","journal-title":"Shock"},{"key":"10.1016\/j.burns.2025.107785_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2015.00133","article-title":"FGF21 and cardiac physiopathology","volume":"6","author":"Planavila","year":"2015","journal-title":"Front Endocrinol"},{"issue":"1","key":"10.1016\/j.burns.2025.107785_bib32","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/oby.22344","article-title":"Pegbelfermin (BMS-986036), PEGylated FGF21, in patients with obesity and type 2 diabetes: results from a randomized phase 2 study","volume":"27","author":"Charles","year":"2019","journal-title":"Obesity"},{"issue":"1","key":"10.1016\/j.burns.2025.107785_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41572-020-0145-5","article-title":"Burn injury","volume":"6","author":"Jeschke","year":"2020","journal-title":"Nat Rev Dis Prim"},{"issue":"19","key":"10.1016\/j.burns.2025.107785_bib34","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1042\/CS20190093","article-title":"Fibroblast growth factor 21 protects against lipotoxicity-induced pancreatic \u03b2-cell dysfunction via regulation of AMPK signaling and lipid metabolism","volume":"133","author":"Xie","year":"2019","journal-title":"Clin Sci"},{"issue":"3","key":"10.1016\/j.burns.2025.107785_bib35","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3390\/cells11030567","article-title":"Brite adipocyte FGF21 attenuates cardiac ischemia\/reperfusion injury in rat hearts by modulating NRF2","volume":"11","author":"Moon","year":"2022","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.burns.2025.107785_bib36","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.burns.2020.07.021","article-title":"Influence of burn severity on endothelial glycocalyx shedding following thermal trauma: a prospective observational study","volume":"47","author":"Tapking","year":"2021","journal-title":"Burns"},{"issue":"4","key":"10.1016\/j.burns.2025.107785_bib37","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jamcollsurg.2017.12.045","article-title":"Contemporary burn survival","volume":"226","author":"Capek","year":"2018","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.burns.2025.107785_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12640-018-9914-2","article-title":"Protective effects of fibroblast growth Factor 21 against amyloid-beta1\u201342-induced toxicity in SH-SY5Y cells","volume":"34","author":"Amiri","year":"2018","journal-title":"Neurotox Res"},{"issue":"8","key":"10.1016\/j.burns.2025.107785_bib39","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1111\/jcmm.17273","article-title":"Fibroblast growth factor 21 reverses high-fat diet-induced impairment of vascular function via the anti-oxidative pathway in ApoE knockout mice","volume":"26","author":"Huang","year":"2022","journal-title":"J Cell Mol Med"},{"issue":"18","key":"10.1016\/j.burns.2025.107785_bib40","doi-asserted-by":"crossref","first-page":"7432","DOI":"10.1073\/pnas.0701600104","article-title":"BetaKlotho is required for metabolic activity of fibroblast growth factor 21","volume":"104","author":"Ogawa","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"37","key":"10.1016\/j.burns.2025.107785_bib41","doi-asserted-by":"crossref","first-page":"26687","DOI":"10.1074\/jbc.M704165200","article-title":"Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21","volume":"282","author":"Kurosu","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.burns.2025.107785_bib42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-physiol-021115-105339","article-title":"Understanding the physiology of FGF21","volume":"78","author":"Fisher","year":"2016","journal-title":"Annu Rev Physiol"},{"issue":"10165","key":"10.1016\/j.burns.2025.107785_bib43","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/S0140-6736(18)31785-9","article-title":"Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial","volume":"392","author":"Sanyal","year":"2019","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.burns.2025.107785_bib44","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S2468-1253(23)00272-8","article-title":"Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial","volume":"8","author":"Harrison","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.burns.2025.107785_bib45","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1073\/pnas.1200797109","article-title":"Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor \u03b3","volume":"109","author":"Wei","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.burns.2025.107785_bib46","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cmet.2013.08.005","article-title":"The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes","volume":"18","author":"Gaich","year":"2013","journal-title":"Cell Metab"},{"issue":"4","key":"10.1016\/j.burns.2025.107785_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.bj.2022.07.002","article-title":"Fibroblast growth factor 21 and bone homeostasis","volume":"46","author":"Tang","year":"2023","journal-title":"Biomed J"},{"issue":"6","key":"10.1016\/j.burns.2025.107785_bib48","doi-asserted-by":"crossref","first-page":"H1029","DOI":"10.1152\/ajpheart.00527.2015","article-title":"Fibroblast growth factors in cardiovascular disease: The emerging role of FGF21","volume":"309","author":"Domouzoglou","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"10.1016\/j.burns.2025.107785_bib49","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI23606","article-title":"FGF-21 as a novel metabolic regulator","volume":"115","author":"Kharitonenkov","year":"2005","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.burns.2025.107785_bib50","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cmet.2007.05.003","article-title":"Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21","volume":"5","author":"Inagaki","year":"2007","journal-title":"Cell Metab"},{"issue":"9","key":"10.1016\/j.burns.2025.107785_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.burns.2024.07.014","article-title":"Outcome comparison of the most commonly employed wound coverage techniques in patients with massive burns \u226550% TBSA - a systematic review and meta-analysis","volume":"50","author":"Haug","year":"2024","journal-title":"Burns"},{"key":"10.1016\/j.burns.2025.107785_bib52","article-title":"A new surgical concept for the efficient treatment of large and deep burns","volume":"46","author":"Hundeshagen","year":"2024","journal-title":"J Burn care Res Publ Am Burn Assoc"},{"key":"10.1016\/j.burns.2025.107785_bib53","unstructured":"Klimitz F., Ritter E., Stolle A., Hundeshagen G., Kneser U., Harhaus-W\u00e4hner L., et al. Evaluation Parameters for Assessing the Effectiveness of Burn Rehabilitation- A Systematic Review. 2024."}],"container-title":["Burns"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417925004140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417925004140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:34:33Z","timestamp":1768566873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305417925004140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0305417925004140"],"URL":"https:\/\/doi.org\/10.1016\/j.burns.2025.107785","relation":{},"ISSN":["0305-4179"],"issn-type":[{"value":"0305-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The burn repair molecule? Evaluating FGF-21 in thermal injury \u2013 A systematic review","name":"articletitle","label":"Article Title"},{"value":"Burns","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.burns.2025.107785","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd and ISBI. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107785"}}